MF

Mark Froimowitz

BG Biofrontera Bioscience Gmbh: 2 patents #2 of 10Top 20%
CC Children'S Medical Center: 2 patents #340 of 1,211Top 30%
BE Board Of Governers For Higher Education: 1 patents #2 of 16Top 15%
SI State of Rhode Island: 1 patents #43 of 143Top 35%
Overall (All Time): #582,812 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
7531573 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease Carlo Brugnara, Jose Halperin, Emile M. Bellot, Jr., Richard John Lombardy, John J. Clifford +8 more 2009-05-12
7511064 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist Hermann Lubbert, Christoph Ullmer, Emile Bellott, Douglas J. Gordon 2009-03-31
7060711 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist Hermann Lubbert, Christoph Ullmer, Emile Bellott, Douglas J. Gordon 2006-06-13
6331564 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease Carlo Brugnara, Jose Halperin, Emile M. Bellot, Jr., Richard John Lombardy, John J. Clifford +8 more 2001-12-18
6262064 Octahydrobenzo[f]quinoline-based receptor agonists and antagonists James N. Jacob 2001-07-17
6028103 Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation Carlo Brugnara, Jose Halperin, Emile M. Bellot, Jr., Richard John Lombardy, John J. Clifford +8 more 2000-02-22
6011070 Slow-onset, long-lasting dopamine reuptake blockers Kuo-Ming Wu 2000-01-04
5863928 Octahydrobenzof!quinoline-based receptor agonists and antagonists James N. Jacob 1999-01-26
5821386 Compounds for treating cocaine abuse Kuo-Ming Wu 1998-10-13